Aplagon
Developer of antithrombotic compounds designed to treat complications of vascular intervention-related blood vessel occlusions. The company's compounds are engaged in developing biological mimetics of...
Valuation
$0
Share Price
N/A
Total Raised
$13.6M
Last Round
N/A